{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:27:22Z","timestamp":1777879642993,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013280","name":"Major Basic Research Project of the Natural Science Foundation of the Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013280","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.phymed.2026.158021","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T08:52:45Z","timestamp":1772095965000},"page":"158021","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Flavonoid GL-V9 as a novel and potent acetyl-coa carboxylase 1 inhibitor confers cisplatin hypersensitivity in ovarian cancer"],"prefix":"10.1016","volume":"154","author":[{"given":"Zihao","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yelin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiawei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeyuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bao-Sheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinglong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongchuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8774-6713","authenticated-orcid":false,"given":"Yongjian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.phymed.2026.158021_bib0001","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1111\/febs.14577","article-title":"Glucose transporters in cancer \u2013 from tumor cells to the tumor microenvironment","volume":"285","author":"Ancey","year":"2018","journal-title":"FEBS. J."},{"issue":"1","key":"10.1016\/j.phymed.2026.158021_bib0002","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1146\/annurev-ento-112408-085356","article-title":"Insect fat body: energy, metabolism, and regulation","volume":"55","author":"Arrese","year":"2010","journal-title":"Annu. Rev. Entomol."},{"issue":"1","key":"10.1016\/j.phymed.2026.158021_bib0003","first-page":"1","article-title":"Structure and regulation of acetyl-CoA carboxylase genes of metazoa","volume":"1733","author":"Barber","year":"2005","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Cell Biol. Lipids"},{"issue":"35","key":"10.1016\/j.phymed.2026.158021_bib0004","doi-asserted-by":"crossref","first-page":"37367","DOI":"10.18632\/oncotarget.5424","article-title":"Role of cystathionine beta synthase in lipid metabolism in ovarian cancer","volume":"6","author":"Chakraborty","year":"2015","journal-title":"Oncotarget."},{"issue":"8","key":"10.1016\/j.phymed.2026.158021_bib0005","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/jpp\/rgae060","article-title":"GL-V9 synergizes with oxaliplatin of colorectal cancer via Wee1 degradation mediated by HSP90 inhibition","volume":"76","author":"Chen","year":"2024","journal-title":"J. Pharm. Pharmacol."},{"issue":"23","key":"10.1016\/j.phymed.2026.158021_bib0006","doi-asserted-by":"crossref","first-page":"10839","DOI":"10.18632\/aging.102488","article-title":"HIF-2\u03b1 upregulation mediated by hypoxia promotes NAFLD-HCC progression by activating lipid synthesis via the PI3K-AKT-mTOR pathway","volume":"11","author":"Chen","year":"2019","journal-title":"Aging (Albany. NY)"},{"issue":"10","key":"10.1016\/j.phymed.2026.158021_bib0007","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1080\/13543784.2019.1657825","article-title":"Acetyl-CoA carboxylase (ACC) as a therapeutic target for metabolic syndrome and recent developments in ACC1\/2 inhibitors","volume":"28","author":"Chen","year":"2019","journal-title":"Expert. Opin. Investig. Drugs"},{"issue":"D1","key":"10.1016\/j.phymed.2026.158021_bib0008","doi-asserted-by":"crossref","first-page":"D1677","DOI":"10.1093\/nar\/gkad896","article-title":"LIPID MAPS: update to databases and tools for the lipidomics community","volume":"52","author":"Conroy","year":"2024","journal-title":"Nucleic. Acids. Res."},{"issue":"1","key":"10.1016\/j.phymed.2026.158021_bib0009","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1039\/B916899K","article-title":"Coordination of platinum therapeutic agents to met-rich motifs of human copper transport protein1","volume":"2","author":"Crider","year":"2010","journal-title":"Metallomics."},{"issue":"11","key":"10.1016\/j.phymed.2026.158021_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107762","article-title":"Patient-derived ovarian cancer organoids mimic clinical response and exhibit heterogeneous inter- and intrapatient drug responses","volume":"31","author":"de Witte","year":"2020","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.phymed.2026.158021_bib0011","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.clnu.2007.07.004","article-title":"Amino acid metabolism and inflammatory burden in ovarian cancer patients undergoing intense oncological therapy","volume":"26","author":"Dillon","year":"2007","journal-title":"Clin. Nutr."},{"issue":"80","key":"10.1016\/j.phymed.2026.158021_bib0012","doi-asserted-by":"crossref","DOI":"10.1039\/c3cc45360j","article-title":"Kinetics and thermodynamics of metal binding to the N-terminus of a human copper transporter, hCTR1","volume":"49","author":"Du","year":"2013","journal-title":"Chem. Commun."},{"key":"10.1016\/j.phymed.2026.158021_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106939","article-title":"Advances in understanding cisplatin-induced toxicity: molecular mechanisms and protective strategies","volume":"203","author":"Elmorsy","year":"2024","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.phymed.2026.158021_bib0014","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejcsup.2020.02.003","article-title":"Anti-angiogenic therapy for ovarian cancer","volume":"15","author":"Garcia Garcia","year":"2020","journal-title":"EJC. Suppl."},{"issue":"1","key":"10.1016\/j.phymed.2026.158021_bib0015","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4161\/cbt.12.1.15721","article-title":"TOFA (5-tetradecyl-oxy-2-furoic acid) reduces fatty acid synthesis, inhibits expression of AR, neuropilin-1 and mcl-1 and kills prostate cancer cells independent of p53 status","volume":"12","author":"Guseva","year":"2014","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.phymed.2026.158021_bib0016","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.2147\/DDDT.S241291","article-title":"Combination therapy of lung cancer using layer-by-layer cisplatin prodrug and curcumin Co-encapsulated nanomedicine","volume":"14","author":"Hong","year":"2020","journal-title":"Drug Des. Devel. Ther."},{"issue":"6","key":"10.1016\/j.phymed.2026.158021_bib0017","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.hoc.2018.07.004","article-title":"Pathogenesis, genetics, and genomics of non\u2013High grade serous ovarian cancers","volume":"32","author":"Ilenkovan","year":"2018","journal-title":"Hematol. Oncol. Clin. North Am."},{"issue":"2","key":"10.1016\/j.phymed.2026.158021_bib0018","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s10103-021-03369-z","article-title":"Combination of cisplatin treatment and photodynamic therapy attenuates cisplatin-induced cell toxicity in A2780 and A2780-CP cervical cancer cell lines","volume":"37","author":"Javani Jouni","year":"2022","journal-title":"Lasers. Med. Sci."},{"issue":"5","key":"10.1016\/j.phymed.2026.158021_bib0019","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/s42255-025-01276-z","article-title":"Metabolic reprogramming of interleukin-17-producing gammadelta T cells promotes ACC1-mediated de novo lipogenesis under psoriatic conditions","volume":"7","author":"Kao","year":"2025","journal-title":"Nat. Metab."},{"issue":"3","key":"10.1016\/j.phymed.2026.158021_bib0020","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0899-9007(99)00266-X","article-title":"Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology","volume":"16","author":"Kuhajda","year":"2000","journal-title":"Nutrition"},{"issue":"2","key":"10.1016\/j.phymed.2026.158021_bib0021","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/humupd\/dml002","article-title":"Endocrine signaling in ovarian surface epithelium and cancer","volume":"13","author":"Leung","year":"2007","journal-title":"Hum. Reprod. Update"},{"issue":"7","key":"10.1016\/j.phymed.2026.158021_bib0022","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2174\/0113894501294182240401060343","article-title":"Cisplatin-based combination therapy for enhanced cancer treatment","volume":"25","author":"Li","year":"2024","journal-title":"Curr. Drug Targets."},{"issue":"2","key":"10.1016\/j.phymed.2026.158021_bib0023","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3892\/mmr.2013.1505","article-title":"TOFA suppresses ovarian cancer cell growth in vitro and in vivo","volume":"8","author":"Li","year":"2013","journal-title":"Mol. Med. Rep."},{"issue":"10","key":"10.1016\/j.phymed.2026.158021_bib0024","doi-asserted-by":"crossref","DOI":"10.3390\/ph17101352","article-title":"GL-V9 promotes autophagy-mediated YAP1 degradation and activates mitochondrial apoptosis in PDAC cells","volume":"17","author":"Liu","year":"2024","journal-title":"Pharmaceuticals. (Basel)"},{"issue":"3","key":"10.1016\/j.phymed.2026.158021_bib0025","doi-asserted-by":"crossref","first-page":"530","DOI":"10.4103\/jcrt.jcrt_792_22","article-title":"Cisplatin-based combination therapy for cancer","volume":"19","author":"Minerva","year":"2023","journal-title":"J. Cancer Res. Ther."},{"issue":"3","key":"10.1016\/j.phymed.2026.158021_bib0026","doi-asserted-by":"crossref","DOI":"10.3390\/cells8030214","article-title":"Hypoxia-inducible factors and the regulation of lipid metabolism","volume":"8","author":"Mylonis","year":"2019","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.phymed.2026.158021_bib0027","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2023.0197","article-title":"Advances in ovarian cancer care and unmet treatment needs for patients with platinum resistance","volume":"9","author":"Richardson","year":"2023","journal-title":"JAMa Oncol."},{"issue":"2","key":"10.1016\/j.phymed.2026.158021_bib0028","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2174\/1568009623666230811093139","article-title":"A comprehensive review on current treatments and challenges involved in the treatment of ovarian cancer","volume":"24","author":"Saman","year":"2024","journal-title":"Curr. Cancer Drug Targets."},{"issue":"11","key":"10.1016\/j.phymed.2026.158021_bib0029","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/nrc.2016.87","article-title":"The metabolic fate of acetate in cancer","volume":"16","author":"Schug","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.phymed.2026.158021_bib0030","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/carcin\/bgaa009","article-title":"RNA-seq reveals novel mechanistic targets of withaferin A in prostate cancer cells","volume":"41","author":"Singh","year":"2020","journal-title":"Carcinogenesis"},{"issue":"2","key":"10.1016\/j.phymed.2026.158021_bib0031","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19020590","article-title":"Multifaceted mechanisms of cisplatin resistance in long-term treated urothelial carcinoma cell lines","volume":"19","author":"Skowron","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.phymed.2026.158021_bib0032","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1002\/jcb.21077","article-title":"Acetyl-coenzyme A carboxylases: versatile targets for drug discovery","volume":"99","author":"Tong","year":"2006","journal-title":"J. Cell Biochem."},{"issue":"1","key":"10.1016\/j.phymed.2026.158021_bib0033","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ygeno.2004.10.001","article-title":"Asymmetric expression of transcripts derived from the shared promoter between the divergently oriented ACACA and TADA2L genes\u2606","volume":"85","author":"Travers","year":"2005","journal-title":"Genomics"},{"issue":"9","key":"10.1016\/j.phymed.2026.158021_bib0034","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1089\/thy.2020.0311","article-title":"Fine-tuning lipid metabolism by targeting mitochondria-associated acetyl-CoA-carboxylase 2 in BRAF(V600E) papillary thyroid carcinoma","volume":"31","author":"Valvo","year":"2021","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.phymed.2026.158021_bib0035","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s42003-025-08031-w","article-title":"HKDC1 promotes ovarian cancer progression through boosting lipid metabolism and immune escape by stabilizing G6PC\/G6PC2","volume":"8","author":"Wang","year":"2025","journal-title":"Commun. Biol."},{"key":"10.1016\/j.phymed.2026.158021_bib0036","article-title":"Acetyl-CoA carboxylases and diseases","volume":"12","author":"Wang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.phymed.2026.158021_bib0037","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.603837","article-title":"Metabolism of amino acids in cancer","volume":"8","author":"Wei","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"16","key":"10.1016\/j.phymed.2026.158021_bib0038","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1158\/1078-0432.CCR-22-0296","article-title":"Single-cell RNA sequencing reveals the tissue architecture in Human high-grade serous ovarian cancer","volume":"28","author":"Xu","year":"2022","journal-title":"Clin. Cancer Res."},{"issue":"23","key":"10.1016\/j.phymed.2026.158021_bib0039","doi-asserted-by":"crossref","first-page":"5135","DOI":"10.1002\/cssc.202101837","article-title":"Research progress on coating structure of silicon anode materials for lithium-ion batteries","volume":"14","author":"Xu","year":"2021","journal-title":"ChemSusChem."},{"issue":"9","key":"10.1016\/j.phymed.2026.158021_bib0040","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.ejca.2004.12.037","article-title":"Co-ordinate activation of lipogenic enzymes in hepatocellular carcinoma","volume":"41","author":"Yahagi","year":"2005","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.phymed.2026.158021_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119196","article-title":"Identification of GL-V9 as a novel senolytic agent against senescent breast cancer cells","volume":"272","author":"Yang","year":"2021","journal-title":"Life Sci."},{"issue":"7","key":"10.1016\/j.phymed.2026.158021_bib0042","first-page":"491","article-title":"GL-V9 reverses adriamycin resistance in hepatocellular carcinoma cells by affecting JNK2-related autophagy","volume":"18","author":"Yang","year":"2020","journal-title":"Chin. J. Nat. Med."},{"issue":"10","key":"10.1016\/j.phymed.2026.158021_bib0043","doi-asserted-by":"crossref","first-page":"16951","DOI":"10.18632\/oncotarget.15208","article-title":"ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cells","volume":"8","author":"Yeung","year":"2017","journal-title":"Oncotarget."},{"issue":"12","key":"10.1016\/j.phymed.2026.158021_bib0044","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1038\/s41418-023-01223-z","article-title":"CDK13 promotes lipid deposition and prostate cancer progression by stimulating NSUN5-mediated m5C modification of ACC1 mRNA","volume":"30","author":"Zhang","year":"2023","journal-title":"Cell Death. Differ."},{"issue":"8","key":"10.1016\/j.phymed.2026.158021_bib0045","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/bph.15997","article-title":"The flavonoid GL-V9 alleviates liver fibrosis by triggering senescence by regulating the transcription factor GATA4 in activated hepatic stellate cells","volume":"180","author":"Zhao","year":"2022","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.phymed.2026.158021_bib0046","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-020-03336-6","article-title":"MIEF2 reprograms lipid metabolism to drive progression of ovarian cancer through ROS\/AKT\/mTOR signaling pathway","volume":"12","author":"Zhao","year":"2021","journal-title":"Cell Death. Dis."},{"key":"10.1016\/j.phymed.2026.158021_bib0047","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.freeradbiomed.2024.01.004","article-title":"MARCH5-mediated downregulation of ACC2 promotes fatty acid oxidation and tumor progression in ovarian cancer","volume":"212","author":"Zhao","year":"2024","journal-title":"Free Radic. Biol. Med."},{"issue":"8","key":"10.1016\/j.phymed.2026.158021_bib0048","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24087585","article-title":"Cisplatin in ovarian cancer treatment-known limitations in therapy force new solutions","volume":"24","author":"Zon","year":"2023","journal-title":"Int. J. Mol. Sci."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326002588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326002588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:49:30Z","timestamp":1777592970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711326002588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":48,"alternative-id":["S0944711326002588"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158021","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Flavonoid GL-V9 as a novel and potent acetyl-coa carboxylase 1 inhibitor confers cisplatin hypersensitivity in ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"158021"}}